Focus on Speculative Grade Healthcare
Low speculative grade ratings make up the vast majority of rated healthcare names and the sector has seen some of the most downgrades and defaults in the past several years. How has it been for 2025 and what are the expectations for the group for 2026? Join us to discuss this large and important group of companies.
Key Topics:
- Outlook for spec grade healthcare for 2026.
- Subsectors to keep an eye on.
- Default activity moderating?
- Credit stats on spec grade healthcare improving?
- Legislative risk wildcards.
Host:
Scott Zari, Director - Pharmaceuticals and Life Sciences
Speakers:
Jack Diebler, Senior Analyst, Healthcare Services
Daniel Hu, Director, Structured Credit
Viktoria Kovalenko, Associate Director, Healthcare Services
Tejaswini Tungare, Associate Director, Healthcare Services
Hanna Zhang, Director, Leveraged Finance
Contact Us
If you have more questions, please feel free to contact our team